These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 10939285)
1. Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati PJ; Brew BJ Redox Rep; 2000; 5(2-3):108-11. PubMed ID: 10939285 [TBL] [Abstract][Full Text] [Related]
2. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ J Neurochem; 2001 Aug; 78(4):842-53. PubMed ID: 11520905 [TBL] [Abstract][Full Text] [Related]
3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279 [TBL] [Abstract][Full Text] [Related]
4. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Guillemin GJ; Smythe G; Takikawa O; Brew BJ Glia; 2005 Jan; 49(1):15-23. PubMed ID: 15390107 [TBL] [Abstract][Full Text] [Related]
6. Expression of the kynurenine pathway enzymes in human microglia and macrophages. Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ Adv Exp Med Biol; 2003; 527():105-12. PubMed ID: 15206722 [TBL] [Abstract][Full Text] [Related]
8. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142 [TBL] [Abstract][Full Text] [Related]
9. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia. Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973 [TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway in depression: A systematic review and meta-analysis. Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993 [TBL] [Abstract][Full Text] [Related]
11. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Heyes MP; Chen CY; Major EO; Saito K Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104 [TBL] [Abstract][Full Text] [Related]
12. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Heyes MP; Achim CL; Wiley CA; Major EO; Saito K; Markey SP Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):595-7. PubMed ID: 8973572 [TBL] [Abstract][Full Text] [Related]